Aptose Biosciences

$2.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-1.52%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell APTO and other stocks, options, ETFs, and crypto commission-free!

About APTO

Aptose Biosciences, Inc. Common Shares, also called Aptose Biosciences, is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Read More Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.

Employees
24
Headquarters
Toronto, Ontario
Founded
1986
Market Cap
114.23M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
153.12K
High Today
$2.68
Low Today
$2.53
Open Price
$2.63
Volume
110.04K
52 Week High
$3.13
52 Week Low
$1.57

Collections

APTO Earnings

-$0.23
-$0.19
-$0.16
-$0.12
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 5, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.